Business Description
Bicycle Therapeutics PLC
NAICS : 325412
SIC : 2834
ISIN : US0887861088
Compare
Compare
Traded in other countries / regions
BCYC.USA50BA.Germany IPO Date
2019-05-23Description
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops which stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical need. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.23 | |||||
| Equity-to-Asset | 0.49 | |||||
| Debt-to-Equity | 0.21 | |||||
| Debt-to-EBITDA | -0.36 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.55 | |||||
| Beneish M-Score | -2.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.9 | |||||
| 3-Year EBITDA Growth Rate | -10.1 | |||||
| 3-Year EPS without NRI Growth Rate | -11.1 | |||||
| 3-Year FCF Growth Rate | -9.1 | |||||
| 3-Year Book Growth Rate | 20.5 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.81 | |||||
| 9-Day RSI | 35.44 | |||||
| 14-Day RSI | 38.04 | |||||
| 6-1 Month Momentum % | 8.59 | |||||
| 12-1 Month Momentum % | -6.68 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.65 | |||||
| Quick Ratio | 5.65 | |||||
| Cash Ratio | 4.71 | |||||
| Days Sales Outstanding | 434.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.4 | |||||
| Shareholder Yield % | -6.69 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -653.07 | |||||
| Net Margin % | -621.69 | |||||
| ROE % | -52.44 | |||||
| ROA % | -32.46 | |||||
| ROIC % | -177.89 | |||||
| ROC (Joel Greenblatt) % | -390.12 | |||||
| ROCE % | -36.55 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 26.61 | |||||
| PB Ratio | 2.77 | |||||
| Price-to-Tangible-Book | 2.77 | |||||
| EV-to-EBIT | -3.16 | |||||
| EV-to-EBITDA | -3.3 | |||||
| EV-to-Revenue | 19.47 | |||||
| EV-to-Forward-Revenue | 9.74 | |||||
| EV-to-FCF | -8.03 | |||||
| Price-to-Net-Current-Asset-Value | 3.5 | |||||
| Price-to-Net-Cash | 5.73 | |||||
| Earnings Yield (Greenblatt) % | -31.65 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BCYC
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bicycle Therapeutics PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 22.518 | ||
| EPS (TTM) ($) | -4.68 | ||
| Beta | 1.39 | ||
| Volatility % | 41.31 | ||
| 14-Day RSI | 38.04 | ||
| 14-Day ATR ($) | 1.146837 | ||
| 20-Day SMA ($) | 21.6675 | ||
| 12-1 Month Momentum % | -6.68 | ||
| 52-Week Range ($) | 18.84 - 33.49 | ||
| Shares Outstanding (Mil) | 36.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bicycle Therapeutics PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bicycle Therapeutics PLC Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bicycle Therapeutics PLC Frequently Asked Questions
What is Bicycle Therapeutics PLC(BCYC)'s stock price today?
The current price of BCYC is $19.93. The 52 week high of BCYC is $33.49 and 52 week low is $18.84.
When is next earnings date of Bicycle Therapeutics PLC(BCYC)?
The next earnings date of Bicycle Therapeutics PLC(BCYC) is 2023-11-03 Est..
Does Bicycle Therapeutics PLC(BCYC) pay dividends? If so, how much?
Bicycle Therapeutics PLC(BCYC) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers